Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Eltrapuldencel-T · NBS-20

Vaccine · Immune activation, directed at melanoma-associated tumor stem cell antigens · developed by Lisata Therapeutics

Phase 3 Most advanced trial (none active)
LSTA Developer
1 Registered trials

What is Eltrapuldencel-T?

Eltrapuldencel-T is an autologous dendritic cell vaccine pulsed with antigens from lethally irradiated, patient-specific melanoma cells and suspended in GM-CSF. It is given subcutaneously to stimulate a cytotoxic T-lymphocyte response against melanoma-associated antigens, and is studied in stage III and stage IV melanoma.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
NBS-20
Drug type
Vaccine
Targets
melanoma-associated tumor stem cell antigens (antigen)
Mechanism
Immune activation, directed at melanoma-associated tumor stem cell antigens
Pathways
cytotoxic T-lymphocyte response, antigen presentation
Therapy area
Oncology
Developer
Lisata Therapeutics, Inc. (LSTA)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 3
UNII
M2LBQ7RN2X

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT01875653 Phase 3 Stage IV Melanoma Terminated LSTA

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Stage III MelanomaStage IV Melanoma

More from Lisata Therapeutics

Sources

Updated Oct 18, 2026. Something wrong or missing? Report it on the LSTA page.

Follow LSTA, the company behind Eltrapuldencel-T

See LSTA's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

LSTA catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.